Skip to main content
Contact Us
Subscribe
E-Edition
79°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zelda Therapeutics Ltd
(OP:
ZLDAF
)
0.1912
UNCHANGED
Streaming Delayed Price
Updated: 11:40 AM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zelda Therapeutics Ltd
< Previous
1
2
3
Next >
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 25, 2024
June 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From June 11, 2024
June 11, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
May 27, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For May 24, 2024
May 24, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For May 8, 2024
May 08, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For April 3, 2024
April 03, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From March 4, 2024
March 04, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For January 22, 2024
January 22, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Friday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
January 05, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Friday For Marijuana Stocks - GreenGro Technologies, Body and Mind Among Top Gainers
December 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For November 27, 2023
November 27, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Thursday For Marijuana Stocks - MPX International, GrowLife Among Top Gainers
November 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From November 15, 2023
November 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 16, 2023
October 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For October 12, 2023
October 12, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023
September 26, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From September 20, 2023
September 20, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?
May 31, 2023
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a leading player in cannabinoid medicine research, has successfully demonstrated that its proprietary drug for diabetic nerve pain, ZLT-L-007,...
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
February 15, 2023
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder...
Via
Benzinga
A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond
November 09, 2022
Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe...
Via
Benzinga
Marijuana Stock Movers For August 9, 2023
August 09, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama
August 15, 2022
By Franca Quarneti via El Planteo.
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Zelira's Zenivol, Clinically Validated Cannabinoid Medication For Insomnia, Gets Regulatory Approval In Germany
July 22, 2022
Zelira Therapeutics Ltd’s (OTCQB: ZLDAF) (ASX:ZLD) insomnia medication Zenivol has achieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market.
Via
Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
July 28, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
July 26, 2023
Via
Benzinga
Cannabis Stock Movers For July 19, 2023
July 19, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.